TP53 and RB1 were the most frequently mutated genes in both SCCE and SCLC patients, mutated in 60% and 54% patients, respectively, in SCCEs, and 64% and 77% in SCLCs. The gene discussed is TP53; the disease is small cell lung carcinoma.